Pediatric study incentives
Executive Summary
Six months of additional market exclusivity would be provided to products for which pediatric studies have been conducted at the request of HHS under legislation (HR 4427) introduced May 16 by Reps. Kreidler (D-Wash.), Rowland (D-Ga.), Unsoeld (D-Wash.) and Swift (D-Wash.). An identical measure (S 2010) was introduced by Sen. Kassebaum (R-Kans.) on April 12